CLARITIN REDITABS- loratadine tablet, orally disintegrating 
Bayer Healthcare LLC.

----------

Claritin ®

RediTabs ®

Drug Facts

Active ingredient (in each tablet)

Loratadine 10 mg

Purpose

Antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

Warnings

Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

When using this product do not take more than directed. Taking more than directed may cause drowsiness.

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

adults and children 6 years and over1 tablet daily; not more than 1 tablet in 24 hours
children under 6 years of ageask a doctor
consumers with liver or kidney diseaseask a doctor

Other information

Inactive ingredients

anhydrous citric acid, gelatin, mannitol, mint flavor

Questions or comments?

1-800-CLARITIN (1-800-252-7484) or www.claritin.com

Distributed by MSD Consumer Care, Inc.,
PO Box 377, Memphis, TN 38151 USA,
a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ USA.

PRINCIPAL DISPLAY PANEL - 10 Tablet Carton

Original Prescription Strength
NDC 11523-7157-2

Non-Drowsy*
Claritin
®
RediTabs®
loratadine 10 mg/antihistamine

Indoor & Outdoor
Allergies

*When taken as directed. See Drug Facts Panel.

24
Hour

Relief of:

No Water Needed
Melts in Your Mouth

10
ORALLY
DISINTEGRATING TABLETS

PRINCIPAL DISPLAY PANEL - 10 Tablet Carton

PRINCIPAL DISPLAY PANEL - 60 Tablet Twin Pack Carton

TWIN PACK

Two 30ct Cartons
60 RediTabs
®

Original Prescription Strength

NDC 11523-4329-1

Non-Drowsy*
Claritin
®
RediTabs®
loratadine 10 mg/antihistamine

Indoor & Outdoor
Allergies

*When taken as directed. See Drug Facts Panel.

24
Hour

Relief of:

No Water Needed
Melts in Your Mouth

60
ORALLY
DISINTEGRATING TABLETS

PRINCIPAL DISPLAY PANEL - 60 Tablet Twin Pack Carton
CLARITIN  REDITABS
loratadine tablet, orally disintegrating
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11523-7157
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE10 mg
Inactive Ingredients
Ingredient NameStrength
GELATIN (UNII: 2G86QN327L)  
MANNITOL (UNII: 3OWL53L36A)  
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize12mm
FlavorMINTImprint Code C10
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11523-7157-21 in 1 CARTON11/27/2002
110 in 1 BLISTER PACK; Type 0: Not a Combination Product
2NDC:11523-7157-33 in 1 CARTON11/27/2002
210 in 1 BLISTER PACK; Type 0: Not a Combination Product
3NDC:11523-7157-42 in 1 CARTON11/27/2002
310 in 1 BLISTER PACK; Type 0: Not a Combination Product
4NDC:11523-7157-74 in 1 CARTON11/27/2002
410 in 1 BLISTER PACK; Type 0: Not a Combination Product
5NDC:11523-7157-85 in 1 CARTON11/27/2002
510 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02070411/27/2002
CLARITIN  REDITABS
loratadine tablet, orally disintegrating
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11523-4329
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE10 mg
Inactive Ingredients
Ingredient NameStrength
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
GELATIN (UNII: 2G86QN327L)  
MANNITOL (UNII: 3OWL53L36A)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize12mm
FlavorMINTImprint Code C10
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11523-4329-12 in 1 PACKAGE, COMBINATION11/27/2002
13 in 1 CARTON
110 in 1 BLISTER PACK; Type 0: Not a Combination Product
2NDC:11523-4329-26 in 1 CARTON11/27/2002
210 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02070411/27/2002
Labeler - Bayer Healthcare LLC. (112117283)

Revised: 11/2019
Document Id: 9689aedf-0359-4d66-e053-2a95a90a1225
Set id: b681ea25-d00b-4c8a-8054-cc6f983ce337
Version: 6
Effective Time: 20191104
 
Bayer Healthcare LLC.